Head-to-Head

Abbott Laboratories vs. Capricor Therapeutics Inc

ABT

Abbott Laboratories

$103.00 -0.84%

VS CAPR

Capricor Therapeutics Inc

$7.59 +0.80%

Abbott Laboratories (ABT) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

ABTCAPR
Market Cap $178.39 billion $441.30 million

ABT leads on 1 of 1 size & scale factors.

Dividend

ABTCAPR
Dividend Yield 2.45% —

ABT and CAPR split the dividend factors evenly.

Risk & Sentiment

ABTCAPR
Short Interest 0.57% 2.65%

ABT leads on 1 of 1 risk & sentiment factors.

Dig deeper: ABT overview, ABT financials, CAPR overview, CAPR financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.